Jack Nathan Medical names CEO Michael Di Cesare as board chair

PUBT · 4d ago
Jack Nathan Medical names CEO Michael Di Cesare as board chair
  • Jack Nathan Medical named CEO Michael Di Cesare chairman effective July 31, 2026; he has led the company’s restructuring since January 2026.
  • Board chairman Blake Lyon resigned effective July 31, 2026; director Anthony DeCristofaro also stepped down the same day.
  • David Parrales was appointed interim CFO effective July 31, 2026; he returned in May 2026 as director of finance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jack Nathan Medical Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607310600NEWSFILECNPR____20260731_307375_1) on July 31, 2026, and is solely responsible for the information contained therein.